Search Within

Advanced Practice Providers

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (192)
  2. Journal Article (122)
  3. Research Letter (3)
  4. Review (3)
  5. Editorial (2)
  6. Book Section (1)
  7. Miscellaneous (1)
Groups
  1. Solid Tumor Oncology Division (324)
  2. Department of Medicine (323)
  3. Nursing (271)
  4. Survivorship Research (152)
  5. Gastrointestinal Oncology Service (137)
  6. Epidemiology and Biostatistics (123)

More Groups

People
  1. Ellen Hollywood (37)
  2. Leonard Saltz (31)
  3. Armin Shahrokni (30)
  4. Diane Reidy (28)
  5. Andrew Epstein (27)
  6. Beatriz Korc-Grodzicki (27)

More People

Years
  1. 2025 (8)
  2. 2024 (22)
  3. 2023 (16)
  4. 2022 (22)
  5. 2021 (23)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (116)
  2. Blood (11)
  3. Cancer (11)
  4. Cancer Research (9)
  5. Clinical Cancer Research (9)
  6. Journal of Pain and Symptom Management (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (132)
  2. Elsevier Inc. (36)
  3. American Association for Cancer Research (27)
  4. Wiley Blackwell (22)
  5. Oxford University Press (15)
  6. American Society of Hematology (12)

More Publishers

Results (324)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The influence of margin width and volume of disease near margin on benefit of radiation therapy after breast-conserving surgery for DCIS: Results of long-term follow-up
    Meeting Abstract

    Rudloff, U.; Brogi, E.; McCormick, B.; Brockway, J. P.; Goldberg, J. I.; Wynveen, C. A.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Clinicopathologic evaluation of papillary carcinoma of the breast
    Meeting Abstract

    Wynveen, C.; Akram, M.; Brzostowski, E.; Nehhozina, T.; Goldberg, J.; Rudloff, U.; Van Zee, K.; Norton, L.; Brogi, E.
    Laboratory Investigation (2009)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Journal Article

    Rudloff, U.; Brogi, E.; Brockway, J. P.; Goldberg, J. I.; Cranor, M.; Wynveen, C. A.; Nehhozina, T.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
    Cancer (2009)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in advanced melanoma
    Meeting Abstract

    Shah, G. D.; Coit, D. G.; Brady, M.; Wolchok, J. D.; Carvajal, R. D.; Busam, K.; Panageas, K.; Roman, R.; Viale, A.; Socci, N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I study of FOLFOX administered with flavopiridol (F) in patients with refractory solid tumors
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M. A.; Cane, L. M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save